Care Delivery

This channel includes news on cardiovascular care delivery, including how patients are diagnosed and treated, cardiac care guidelines, policies or legislation impacting patient care, device recalls that may impact patient care, and cardiology practice management.

RSS icon
AI in healthcare

Said and heard this week in and around healthcare

10 notable quotes about AI from the past 5 days.

Thumbnail

Cardiologists say heart patients are often their own worst enemy

Patient lifestyles represent a significant challenge when treating and managing heart patients, according to a survey of more than 400 cardiologists. 

Medicare data stethoscope healthcare trends graphs finance financials

Cardiology groups cheer new bill that would improve access to Medicare claims data

If passed, this bill would help clinician-led clinical registries explore Medicare data for research purposes. The Society of Thoracic Surgeons and American College of Cardiology both shared public support for the bipartisan legislation. 

cardiologist viewing heart data

Long-term survival after valve-in-valve TAVR similar with self-expanding, balloon-expandable valves

Severe prosthesis-patient mismatch was more common with balloon-expandable valves, but that difference did not appear to impact outcomes. 

artificial intelligence AI in healthcare

Industry Watcher’s Digest

Primary care could use a break. AI might be able to supply it. 

artificial intelligence AI in the C suite

It’s 2024. Does the C-suite know—or care—what workers are doing with generative AI?

In the rush to do something, anything with AI, are America’s business leaders playing fast and loose with the risks? 

Thumbnail

Watchdog group, fearful of fraud, wants more oversight for remote patient monitoring

Cardiologists and other physicians may soon need to provide much more information when ordering remote patient monitoring for Medicare patients.

A majority of medical devices involved in Class I recalls were never required by the U.S. Food and Drug Administration (FDA) to undergo premarket or postmarket clinical testing, according to new research published in Annals of Internal Medicine.[1]

Most recalled cardiovascular devices gained FDA approval with little to no clinical evidence

Why are so many cardiovascular devices involved in Class I recalls? One possible reason could be the large number of devices hitting the market without undergoing much premarket clinical testing. 

Displaying 545 - 552 of 1501
Design by Adaptive Theme